title: Simvastatin, fenofibrate, and rhabdomyolysis.
authors.forename: Sindhu S
authors.initials: SS
authors.lastname: Jacob
authors.forename: Sony
authors.initials: S
authors.lastname: Jacob
authors.forename: Craig
authors.initials: C
authors.lastname: Williams
authors.forename: Mark A
authors.initials: MA
authors.lastname: Deeg
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004359:Drug Therapy, Combination; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin / Q000009:adverse effects*
chemical_list: D000960:Hypolipidemic Agents; D019821:Simvastatin; D011345:Fenofibrate